1. Home
  2. ICCC vs CODX Comparison

ICCC vs CODX Comparison

Compare ICCC & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • CODX
  • Stock Information
  • Founded
  • ICCC 1982
  • CODX 2013
  • Country
  • ICCC United States
  • CODX United States
  • Employees
  • ICCC N/A
  • CODX N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • CODX Medical/Dental Instruments
  • Sector
  • ICCC Health Care
  • CODX Health Care
  • Exchange
  • ICCC Nasdaq
  • CODX Nasdaq
  • Market Cap
  • ICCC 35.4M
  • CODX 33.2M
  • IPO Year
  • ICCC 1987
  • CODX 2017
  • Fundamental
  • Price
  • ICCC $4.06
  • CODX $1.21
  • Analyst Decision
  • ICCC
  • CODX Hold
  • Analyst Count
  • ICCC 0
  • CODX 1
  • Target Price
  • ICCC N/A
  • CODX $2.00
  • AVG Volume (30 Days)
  • ICCC 7.2K
  • CODX 82.9K
  • Earning Date
  • ICCC 08-08-2024
  • CODX 08-08-2024
  • Dividend Yield
  • ICCC N/A
  • CODX N/A
  • EPS Growth
  • ICCC N/A
  • CODX N/A
  • EPS
  • ICCC N/A
  • CODX N/A
  • Revenue
  • ICCC $21,282,719.00
  • CODX $6,677,935.00
  • Revenue This Year
  • ICCC N/A
  • CODX N/A
  • Revenue Next Year
  • ICCC N/A
  • CODX N/A
  • P/E Ratio
  • ICCC N/A
  • CODX N/A
  • Revenue Growth
  • ICCC 32.89
  • CODX N/A
  • 52 Week Low
  • ICCC $4.05
  • CODX $0.98
  • 52 Week High
  • ICCC $5.69
  • CODX $1.73
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 38.96
  • CODX 43.56
  • Support Level
  • ICCC $4.05
  • CODX $1.20
  • Resistance Level
  • ICCC $4.29
  • CODX $1.30
  • Average True Range (ATR)
  • ICCC 0.10
  • CODX 0.09
  • MACD
  • ICCC -0.01
  • CODX -0.01
  • Stochastic Oscillator
  • ICCC 4.00
  • CODX 5.26

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: